title: Lymphomatoid Granulomatosis with Central Nervous System Involvement Successfully Treated with Cyclophosphamide, High-dose Cytarabine, Dexamethasone, Etoposide, and Rituximab (CHASER therapy) Followed by Brain Irradiation: A Case Study.
authors.affiliation: Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.|Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
authors.forename: Motoki
authors.initials: M
authors.lastname: Fujimaki
authors.affiliation: Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
authors.forename: Sumihiro
authors.initials: S
authors.lastname: Kawajiri
authors.affiliation: Department of Hematology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
authors.forename: Kunimoto
authors.initials: K
authors.lastname: Ichikawa
authors.affiliation: Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
authors.forename: Yuji
authors.initials: Y
authors.lastname: Tomizawa
authors.affiliation: Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.|Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
authors.forename: Tomoko
authors.initials: T
authors.lastname: Nakazato
authors.affiliation: Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Noda
authors.affiliation: Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
authors.forename: Nobutaka
authors.initials: N
authors.lastname: Hattori
authors.affiliation: Department of Hematology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
authors.forename: Michiaki
authors.initials: M
authors.lastname: Koike
authors.affiliation: Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Okuma
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008230:Lymphomatoid Granulomatosis / Q000188:drug therapy* / Q000532:radiotherapy*; D000069283:Rituximab / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D003561:Cytarabine; D000069283:Rituximab; D005047:Etoposide; D003907:Dexamethasone; D003520:Cyclophosphamide